Science
Mechanism of Action
The primary mechanism of Cymbopogon schoenanthus oil is attributed to its constituent compounds. Citral is responsible for its notable antibacterial and antimicrobial activities, while limonene contributes to its anti-inflammatory effects. The oil also functions as a tonic, promoting a refreshed skin sensation, and can help normalize sebum production in overactive glands.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Demonstrated effective antibacterial activity at 5% concentration against various bacteria, including *Klebsiella pneumoniae*, *Pseudomonas aeruginosa*, *Corynebacterium sp.*, *Enterococcus faecalis*, and *Staphylococcus aureus*.
- 02 Achieved Minimum Inhibitory Concentration (MIC) against *Klebsiella pneumoniae* and Methicillin-sensitive *Staphylococcus aureus* (MSSA) at 2.34 µg/ml.
- 03 Showed Minimum Inhibitory Concentration (MIC) against Methicillin-resistant *Staphylococcus aureus* (MRSA) at 4.69 µg/ml.
- 04 Exhibited antifungal and anti-inflammatory activity, noted for its potential in preventing and treating acute inflammatory skin conditions, though specific oil concentrations were not detailed for these findings.
- 05 Demonstrated significant wound-healing activity, achieving 99.35 ± 0.12% wound contraction by the 20th day, a result comparable to a 1% allantoin positive control, with oil concentration not specified.
Transparency
Dusting Analysis
Cymbopogon schoenanthus oil is not typically 'dusted' in formulations for exaggerated or unsubstantiated efficacy claims. Its biological activities, particularly antibacterial and anti-inflammatory, are supported by some research. However, its significant safety concerns, rather than a lack of efficacy, are the primary factor requiring caution in formulation.
The Formula
Formulation
Conflicts
- Contains declarable EU allergens (citral, limonene, geraniol, farnesol) that pose a risk of allergic reactions and skin sensitization.
- Requires significant dilution for safe topical application due to its potential for skin irritation and sensitization.
- Exhibits enhanced skin absorption, potentially increasing systemic exposure to its irritating components.
- Potential for upper respiratory tract irritation upon inhalation.
Safety
Safety Profile
The European Commission's SCCS has identified Cymbopogon schoenanthus oil as an established human contact allergen, necessitating restrictions under Annex III of the EC Cosmetics Regulation. It contains mandatory declarable allergens such as citral, limonene, geraniol, and farnesol. While the US FDA lists it as safe for general food use, its high irritancy and sensitization potential preclude unconstrained topical application. High doses have also been linked to kidney toxicity and hyperplasia in laboratory animals.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite possessing antibacterial and anti-inflammatory properties, Cymbopogon schoenanthus oil is an established human contact allergen with high irritancy, making it unsuitable for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…